Target intelligence / Profile preview

Prevotella bivia

Molecular classification
Bacteria, Gram-negative anaerobe, Member of Bacteroidota/Bacteroidia (taxonomic family)
01

Overview

Prevotella bivia is a gram-negative, anaerobic rod-shaped bacterium frequently found in the female genital tract, especially in cases of bacterial vaginosis, pelvic inflammatory disease, and associated infections such as endometritis and chorioamnionitis[1][3][4][5]. It is notable for producing ammonia and sialidase, both of which promote the growth and persistence of other vaginal pathogens, degrade cervicovaginal mucus, and support the formation of antibiotic-resistant biofilms[2][3][4]. The organism demonstrates significant resistance to key antibiotics (metronidazole, clindamycin, ceftriaxone), complicating management and contributing to recurrence of infections[3]. Prevotella bivia is detected by molecular assays targeting its DNA and by measurement of sialidase activity, which serves as a diagnostic marker for problematic vaginal microbiota states such as BV[4]. Because of its association with persistent and recurrent genital tract infections and its biofilm-forming capabilities, it remains a focus for research into both diagnostics and infection control strategies.

Other names
P. bivia
02

Mechanism of action

Antibiotics generally target cell wall synthesis (beta-lactams), DNA replication (metronidazole), or protein synthesis (clindamycin). Resistance mechanisms can include efflux pumps, biofilm-mediated protection, and enzymatic drug inactivation

03

Biological functions

Ammonia and amino acid production (promotes growth of other vaginal pathogens)Sialidase enzyme production (degrades cervicovaginal mucus, assists biofilm formation)Biofilm formation and persistence in vaginal infectionsAntibiotic resistance (notable for resistance to clindamycin, ceftriaxone, metronidazole)
04

Disease associations

Bacterial vaginosisPelvic inflammatory diseaseEndometritisChorioamnionitisOther vaginal and genital tract infections
05

Safety considerations

Antibiotic resistance (limits therapeutic options)Persistence and recurrence due to biofilm formation (biofilm acts as a barrier to antibiotics and promotes resistance)Dense polymicrobial colonization and interactions with other pathogens enhance treatment failure rates in BV
06

Interacting drugs

Metronidazole

3 more in the full profile.

07

Biomarkers

Presence of Prevotella bivia DNA or sialidase activity in vaginal/clinical samples is a biomarker for bacterial vaginosis and persistent or recurrent BVAmmonia production and biofilm presence in microbiota analysis

Beyond the preview

Go deeper on Prevotella bivia.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prevotella bivia.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call